Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.
Larkin RM, Lopez DC, Robbins YL, Lassoued W, Canubas K, Warner A, Karim B, Vulikh K, Hodge JW, Floudas CS, et al. J Transl Med. 2024 May 31; 22(1):524. Epub 2024 May 31.